Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers Calendar > Headlines for 2006 > News item |
FDA Calendar
June 17-22, Salt Lake City
20th ANNIVERSARY MEETING OF THE ASSOCIATED PROFESSIONAL SLEEP SOCIETIES
Includes presentation from Sepracor Inc. on data for Lunesta brand eszopiclone for the treatment of insomnia and presentation from Somaxon Pharmaceuticals Inc. on phase 2 clinical trials evaluating three doses of Silenor in elderly adults with insomnia
June 17-22, Scottsdale, Ariz.
ANNUAL MEETING OF THE COLLEGE ON PROBLEMS OF DRUG DEPENDENCE
Includes presentation from New River Pharmaceuticals Inc. on clinical abuse liability studies for NRP104, a compound for ADHD
June 21-24, Amsterdam
EUROPEAN LEAGUE AGAINST RHEUMATISM 2006 ANNUAL CONGRESS
Includes presentation from Savient Pharmaceuticals Inc. on phase 2 trial results for Puricase and presentation from CombinatoRx Inc. on phase 2 trial of CRx-102 for osteoarthritis
June 21-23, Toulon, France
14TH INTERNATIONAL SYMPOSIUM ON HIV AND EMERGING INFECTIOUS DISEASES
Includes presentation from Adventrx Pharmaceuticals Inc. on antiviral activity of Thiovir
June 22-23, Gaithersburg, Md.
CIRCULATORY SYSTEM DEVICES PANEL OF THE MEDICAL DEVICES ADVISORY COMMITTEE MEETING (FDA)
Committee to discuss, make recommendations and vote on a premarket approval application for a cardiac device intended to treat patients with heart failure as well as humanitarian device exemption for an artificial heart
June 22-24, Lisbon, Portugal
XXII WORLD CONGRESS OF THE INTERNATIONAL UNION OF ANGIOLOGY
Includes presentation from Gentium SpA on Defibrotide as an anti-thrombotic and anti-ischemic drug for veno-occlusive disease
June 22-25, Los Angeles
48th ANNUAL AMERICAN HEADACHE SOCIETY MEETING
Includes presentation from Alexza Pharmaceuticals on phase 2a clinical trial for Staccato Prochlorperazine for the acute treatment of migraine headache
June 23, Gaithersburg, Md.
OBSTETRICS AND GYNECOLOGY DEVICES PANEL OF THE MEDICAL DEVICES ADVISORY COMMITTEE MEETING (FDA)
Committee to hear a presentation on the FDA Critical Path Initiative; to discuss, make recommendations and vote on a premarket approval application for a fetal heart monitoring device that, in addition to standard features, is used during labor and delivery to measure, display and analyze the ST waveform of the fetal electrocardiogram
June 24-27, Boston
THE ENDOCRINE SOCIETY'S 88th ANNUAL MEETING
Includes presentation from Manhattan Pharmaceuticals Inc. on effect of chronic or intermittent oral administration of Oleoyl-estrone on food intake, body weight and body composition in normal rats and presentation from GTx, Inc. on preclinical studies describing the bone-promoting activities and possible mechanisms for tissue selectivity with its selective androgen receptor modulators
June 26-27, Philadelphia
2006 TARGETING UBIQUITIN FOR DRUG DISCOVERY AND DEVELOPMENT CONFERENCE
Includes presentation from Rigel Pharmaceuticals Inc. on mechanisms of ubiquitin chain synthesis onto substrates of SCF ubiquitin ligases
June 28, Rockville, Md.
PEDIATRIC ETHICS SUBCOMMITTEE OF THE PEDIATRIC ADVISORY COMMITTEE MEETING (FDA)
Committee to discuss a referral by an Institutional Review Board of a proposed clinical investigation that involves both an FDA regulated product and research involving children as subjects that may be supported by HHS titled "Precursor Preference in Surfactant Synthesis of Newborns"
June 28-July 1, Barcelona
8th WORLD CONGRESS ON GASTROINTESTINAL CANCER
Includes presentation from Adventrx Pharmaceuticals Inc. on the response to CoFactor, a folate-based biomodulator drug designed to enhance the activity and reduce associated toxicity of the widely used cancer chemotherapeutic agent 5-fluorouracil
June 29-30, Rockville, Md.
PEDIATRIC ADVISORY COMMITTEE MEETING (FDA)
Committee to hear and discuss the recommendation of the Pediatric Ethics Subcommittee regarding a referral by an Institution Review Board of a proposed clinical investigation involving children as subjects that is regulated by FDA and is conducted or supported by DHHS; to discuss a report by the agency on Adverse Event Reporting for ethinyl estradiol; norgestimate (Ortho Tri-Cyclen), ciprofloxacin (Cipro), tolterodine (Detrol LA), leflunomide (Arave), paricalcitol (Zemplar), zolmitriptan (Zomig), dorzolamide Trusopt
July 11, Rio Grande, Puerto Rico
ANNUAL MEETING OF THE AMERICAN SOCIETY FOR PHOTOBIOLOGY
Includes presentation from Provectus Pharmaceuticals on its topical drug Xantryl for infections caused by highly dangerous antibiotic resistant bacteria
July 9-13, Chicago
25th BIENNIAL CONGRESS OF THE COLLEGIUM INTERNATIONALE NEURO-PSYCHOPHARMOCOLOGICUM
Includes presentation from DOV Pharmaceutical Inc. on phase 3 trial of bicifadine in patients with chronic low back pain
July 12-15, Washington
13th WORLD CONFERENCE ON TOBACCO OR HEALTH
Includes presentation from Nymox Pharmaceutical Corp. on results for saliva NicAlert test for tobacco exposure
July 13-14, Gaithersburg, Md.
PULMONARY-ALLERGY DRUGS ADVISORY COMMITTEE MEETING (FDA)
Includes discussion on the implications of recently available data related to the safety of long-acting beta-agonist bronchodilators and the continued need for the essential use designations of prescription drugs for the treatment of asthma and chronic obstructive pulmonary disease
July 13-15, Greenbelt, Md.
FOOD ADVISORY COMMITTEE MEETING (FDA)
Includes evaluation on the CFSAN Threshold Working Group draft report "Approaches to Establish Thresholds for Major Food Allergens and Gluten" as well as discussion on the draft report's approaches for food allergen thresholds and gluten thresholds
July 15, Gaithersburg, Md.
IMMUNOLOGY DEVICES PANEL OF THE MEDICAL DEVICES ADVISORY COMMITTEE MEETING (FDA)
Committee to hear presentation on the FDA Critical Path Initiative and a presentation by the Office of Surveillance and Biometrics in the Center for Devices and Radiological Health outlining their responsibility for the review of postmarket study design; to discuss, make recommendations and vote on a premarket approval application for a laboratory assay designed to measure levels of neural thread protein in urine specimens from patients presenting with cognitive complaints or other signs and symptoms of suspected Alzheimer's disease
July 23-27, Chicago
AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY ANNUAL MEETING
Includes presentation by PreMD Inc. on abstract for microwell-based format of LungAlert for lung cancer
July 27-28, Tyson's Corner, Va.
2nd ANNUAL OBESITY DRUG DEVELOPMENT SUMMIT
Includes presentation from Manhattan Pharmaceuticals Inc. on oral Oleoyl-estrone for obesity
Sept. 2-6, Barcelona
WORLD CONGRESS OF CARDIOLOGY 2006
Includes presentation from Vasogen Inc. on phase 3 Acclaim trial of Celacade technology in advanced chronic heart failure
Sept. 3-8, Sydney, Australia
10th INTERNATIONAL CONGRESS ON OBESITY
Includes presentation from Manhattan Pharmaceuticals Inc. on long-term treatment of zucker obese rats with Oleoyl-estrone to decrease expression of pro-inflammation markers in white adipose tissue
Sept. 10-14, Edinburgh, Scotland
INTERNATIONAL CONGRESS OF CLINICAL NEUROPHYSIOLOGY
Includes presentation from Nymox Pharmaceutical Corp. on AlzheimAlert, a urine-based diagnostic aid
Sept. 14-17, Copenhagen
42nd EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES CONFERENCE
Includes presentation from CeNeS Pharmaceuticals plc on CNS 5161, a neuronal glutamate receptor antagonist
Oct. 14-18, Chicago
AMERICAN SOCIETY FOR ANESTHESIOLOGY MEETING
Includes presentation from CeNeS Pharmaceuticals plc on short-acting sedative CNS 7056X for use in the induction and maintenance of anesthesia
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.